The MET oncogene, encoding the hepatocyte growth factor (HGF) receptor, drives invasive growth, a genetic programme largely overlapping with the epithelial-to-mesenchymal transition and governing physiological and pathological processes such as tissue development and regeneration, as well as cancer. Here, MET is linked to cancer.